Broker spotlight - Shire, Glaxo, Barclays, William Hill, Kaz Minerals

Drug company Shire (LON:SHP) is in good health, Jefferies reckons. The stockbroker upped its target price on Shire shares this morning by 6% to 6150p and stuck with its ‘buy’ rating. It...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]

http://ift.tt/1dzLVo5 @MasterMetals MasterMetals Blog